190 related articles for article (PubMed ID: 15370618)
1. Severe neurotoxicity caused by gemcitabine treatment.
Larsen FO; Hansen SW
Acta Oncol; 2004; 43(6):590-1. PubMed ID: 15370618
[No Abstract] [Full Text] [Related]
2. [Toxicity of intravesical gemcitabine in superficial bladder cancer treatment].
Beardo Villar P; Gamaza Martínez R; Gavira Moreno R
Farm Hosp; 2014 May; 38(3):249-51. PubMed ID: 24951911
[TBL] [Abstract][Full Text] [Related]
3. Role of gemcitabine in cancer therapy.
Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
[TBL] [Abstract][Full Text] [Related]
4. Intravesical gemcitabine for superficial bladder cancer: rationale for a new treatment option.
Gontero P; Marini L; Frea B
BJU Int; 2005 Nov; 96(7):970-6. PubMed ID: 16225511
[No Abstract] [Full Text] [Related]
5. Toxic epidermal necrolysis associated with gemcitabine therapy in a patient with metastatic transitional cell carcinoma of the bladder.
Mermershtain W; Cohen AD; Lazarev I; Grunwald M; Ariad S
J Chemother; 2003 Oct; 15(5):510-1. PubMed ID: 14598945
[TBL] [Abstract][Full Text] [Related]
6. [Updates on gemcitabine at the American Society of Clinical Oncology congress (ASCO, 2002) ].
Gligorov J; André T; Epaud C; Culine S
Bull Cancer; 2002 Aug; 89 Spec No():S134-44. PubMed ID: 12449045
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine and vascular toxicity.
Muñoz A; Mañé JM; Rubio I; Fernández R; Fuente N; Barceló R; López Vivanco G
Lung Cancer; 2002 Aug; 37(2):229. PubMed ID: 12140148
[No Abstract] [Full Text] [Related]
8. [Severe ischemic myopathy localized in an irradiated area following gemcitabine therapy].
Pariente A; Berthelémy P; Arotçarena R; Bénichou M; Calès V; Dujols JP
Presse Med; 2000 Oct; 29(30):1650. PubMed ID: 11089501
[No Abstract] [Full Text] [Related]
9. Hemolytic-uremic syndrome caused by gemcitabine.
Nackaerts K; Daenen M; Vansteenkiste J; Vandevelde A; Van Bleyenbergh P; Demedts M
Ann Oncol; 1998 Dec; 9(12):1355. PubMed ID: 9932169
[No Abstract] [Full Text] [Related]
10. Gemcitabine for lung cancer.
Drug Ther Bull; 1996 Sep; 34(9):71-2. PubMed ID: 8885499
[No Abstract] [Full Text] [Related]
11. Fatal pulmonary veno-occlusive disease possibly related to gemcitabine.
Vansteenkiste JF; Bomans P; Verbeken EK; Nackaerts KL; Demedts MG
Lung Cancer; 2001 Jan; 31(1):83-5. PubMed ID: 11162870
[No Abstract] [Full Text] [Related]
12. Veno-occlusive disease of the liver induced by gemcitabine.
Dobbie M; Hofer S; Oberholzer M; Herrmann R
Ann Oncol; 1998 Jun; 9(6):681. PubMed ID: 9681086
[No Abstract] [Full Text] [Related]
13. [Gemcitabine: a new chemotherapy agent for solid cancers].
Klastersky J; Awada A
Rev Med Brux; 1997 Oct; 18(5):328-34. PubMed ID: 9441329
[TBL] [Abstract][Full Text] [Related]
14. An unusual case of gemcitabine-induced radiation recall.
Squire S; Chan M; Feller E; Mega A; Gold R
Am J Clin Oncol; 2006 Dec; 29(6):636. PubMed ID: 17149004
[No Abstract] [Full Text] [Related]
15. Gemcitabine in bladder cancer.
El Karak F; Flechon A
Expert Opin Pharmacother; 2007 Dec; 8(18):3251-6. PubMed ID: 18035967
[TBL] [Abstract][Full Text] [Related]
16. Acute generalized exanthematous pustulosis caused by gemcitabine.
George J; De D; Mahajan R; Saikia UN; Kanwar AJ
Int J Dermatol; 2014 Mar; 53(3):e184-5. PubMed ID: 23621765
[No Abstract] [Full Text] [Related]
17. Gemcitabine hydrochloride: combination of activity and tolerability. Proceedings of a symposium. Jerusalem, Israel, November 14, 1993.
Anticancer Drugs; 1995 Dec; 6 Suppl 6():5-65. PubMed ID: 8718418
[No Abstract] [Full Text] [Related]
18. Purtscher retinopathy and necrotizing vasculitis with gemcitabine therapy.
Banach MJ; Williams GA
Arch Ophthalmol; 2000 May; 118(5):726-7. PubMed ID: 10815173
[No Abstract] [Full Text] [Related]
19. Gemcitabine: new indication. Relapsed ovarian cancer: simply more toxic. Increases haematologic toxicity but not overall survival.
Prescrire Int; 2009 Aug; 18(102):156. PubMed ID: 19746525
[No Abstract] [Full Text] [Related]
20. Radiation myositis: the possible role of gemcitabine.
Ganem G; Solal-Celigny P; Joffroy A; Tassy D; Delpon A; Dupuis O
Ann Oncol; 2000 Dec; 11(12):1615-6. PubMed ID: 11205473
[No Abstract] [Full Text] [Related]
[Next] [New Search]
